Today The #FDA approved JULUCA the first 2 drug complete regimen to treat select individuals who are virally suppressed. The regimen contains integrase inhibitor dolutegravir and NNRTI rilpivirine.
Dolutegravir is also
By Emily Kopp
The pharmaceutical industry could see windfall profits from a little-noticed tweak to the insurance market tucked into the Trump administration’s draft executive order on drug prices,
By Ana B. Ibarra
Civil rights advocates sued California on Wednesday, alleging that care provided by Medi-Cal, the state’s health program for low-income people, is substandard and disproportionately